3D Bead ELISA for Sensitive Extracellular Vesicle Profiling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for quantifying membrane and cargo proteins from extracellular vesicles, such as Western Blotting, ELISA, and flow analysis, suffer from low sensitivity, non-specific binding, and require expensive equipment, making it difficult to accurately detect and quantify low-represented populations of disease-specific exosomes.

Innovation Solution

A 3D ELISA technique using beads as a support in microplate wells or on filter membranes, coated with crosslinking reagents and antibodies, allows for the immobilization and quantification of extracellular vesicles and their proteins, enhancing sensitivity and reducing non-specific binding.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If classical ELISA is used for protein quantification, then the method is simple and widely used, but sensitivity is limited due to non-specific binding and slow binding kinetics

Engineering Contradiction:
ImprovesensitivityVSAvoidmethod complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent transitions from classical 2D ELISA (flat plate surface) to 3D ELISA using beads as support. This dimensional change increases the surface area available for antibody binding by orders of magnitude, thereby increasing sensitivity and reducing non-specific binding while maintaining operational simplicity

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent introduces beads as intermediary elements between the antigen (extracellular vesicles) and the detection system. These beads serve as a 3D support that enhances binding kinetics and signal detection while minimizing non-specific interactions, thus improving sensitivity without complicating the overall method

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If flow analysis with antibody-coated beads is used, then EVs transmembrane proteins can be quantified with good sensitivity, but the method is time-consuming and requires expensive equipment

Engineering Contradiction:
ImprovesensitivityVSAvoidincubation time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces the mechanical flow cytometry system with a 3D ELISA-based detection system. This substitution eliminates the need for expensive flow cytometers while maintaining sensitivity through the 3D bead support that enhances antigen-antibody binding efficiency, thereby reducing both equipment costs and analysis time

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Ease of manufacture

If Western Blotting is used for protein detection, then the method is simple, but it is semi-quantitative and not suitable for accurate quantification

Engineering Contradiction:
Improvemethod simplicityVSAvoidquantification accuracy
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The patent applies 3D bead support to ELISA, transforming it from a 2D surface-based assay to a 3D volume-based assay. This dimensional enhancement provides both the simplicity of ELISA and the accuracy of quantification by enabling precise measurement of protein concentrations through optimized binding kinetics and signal detection

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The 3D ELISA technique significantly accelerates reaction kinetics, reduces non-specific binding, and increases sensitivity, enabling efficient profiling of both membrane and cargo proteins from extracellular vesicles, even in low-concentration solutions.

Implementation Method 1

The beads have a surface functionality allowing to immobilize the total extracellular vesicles population or to immobilize the entire set of proteins from lysed EVs

Methodology Applied
Scientific EffectCrosslinking: Chemical Bonding

Implementation Method 2

The approach is based on positive selection of target EVs population with antibody-coated beads followed by immunostaining of bead-bond vesicles

Methodology Applied
Scientific EffectImmune complex formation: Adhesive

Data Source

PatentEP4614144A1Method for immunodetection of membrane and cargo protein markers on extracellular vesicles
Publication Date: 2025.09.10 EXOSOME ANALYTICS
  • EP4614144A1 patent drawingFigure 1A
  • EP4614144A1 patent drawingFigure 1B
  • EP4614144A1 patent drawingFigure 1C

AI summary

The invention relates to a method for the profiling of membrane and cargo proteins from extracellular vesicles (in combination or without simultaneous isolation of extracellular vesicles) consisting of a 3D ELISA technique, where the 3D support is beads placed in the wells of a microplate or in microtubes ("in the volume" reaction model) or on the surface of a filter membrane ("filtration" reaction model) and putted in contact with the extracellular vesicles.